Literature DB >> 15642543

Heart failure after myocardial infarction: clinical presentation and survival.

Jens P Hellermann1, Steven J Jacobsen, Margaret M Redfield, Guy S Reeder, Susan A Weston, Véronique L Roger.   

Abstract

OBJECTIVES: To characterize the presentation and outcome of patients with heart failure (HF) after myocardial infarction (MI) according to left ventricular ejection fraction (LVEF) and test the hypothesis that the outcome of HF did not change over time.
BACKGROUND: Little is known about the presentation and outcome of HF post-MI and how these may have changed over time.
METHODS: Using the Rochester Epidemiology Project, all residents of Olmsted County, Minnesota who experienced an incident MI between 1979 and 1998 were identified; MI and HF were validated using standardized criteria. Subjects were followed through their community medical record.
RESULTS: Between 1979 and 1998, 1915 patients with incident MI and no prior history of HF were identified. Of these, 791(41%) experienced new onset HF as defined by Framingham criteria during 6.6+/-5.0 years of follow-up. Forty-seven percent were men, mean age was 73+/-12 years. Forty-four percent had impaired LVEF, 18% preserved LVEF and 38% had no LVEF measurement within 60 days after the HF event. Median survival after HF onset was 4 years and at 5 years after HF onset, only 45% were alive. Older age, male sex, comorbidity, hypertension and no LVEF assessment were associated with increased risk of death, however, patients with impaired LVEF had the worst outcome. Over time, survival did not improve (HR for year: 1.00; 95% CI 0.99, 1.02; P=0.919) even after adjustment for baseline characteristics.
CONCLUSION: In this geographically defined cohort of patients with MI, new onset HF after the MI was frequent. When measured, LVEF was most frequently reduced, consistent with systolic heart failure. Mortality was high and did not decline over time and death was independently associated with male sex, older age, hypertension and comorbidity. It also differed according to LVEF, which was inconsistently ascertained in this setting, potentially representing practice opportunities.

Entities:  

Mesh:

Year:  2005        PMID: 15642543     DOI: 10.1016/j.ejheart.2004.04.011

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  29 in total

Review 1.  Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling.

Authors:  Merry L Lindsey; Rugmani Padmanabhan Iyer; Mira Jung; Kristine Y DeLeon-Pennell; Yonggang Ma
Journal:  J Mol Cell Cardiol       Date:  2015-12-23       Impact factor: 5.000

Review 2.  Restrictive diastolic filling predicts death after acute myocardial infarction: systematic review and meta-analysis of prospective studies.

Authors:  G A Whalley; G D Gamble; R N Doughty
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

3.  Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.

Authors:  Christoph Rischpler; Ralf J Dirschinger; Stephan G Nekolla; Hans Kossmann; Stefania Nicolosi; Franziska Hanus; Sandra van Marwick; Karl P Kunze; Alexander Meinicke; Katharina Götze; Adnan Kastrati; Nicolas Langwieser; Tareq Ibrahim; Matthias Nahrendorf; Markus Schwaiger; Karl-Ludwig Laugwitz
Journal:  Circ Cardiovasc Imaging       Date:  2016-04       Impact factor: 7.792

Review 4.  Medical Therapy for Heart Failure Caused by Ischemic Heart Disease.

Authors:  Islam Y Elgendy; Dhruv Mahtta; Carl J Pepine
Journal:  Circ Res       Date:  2019-05-24       Impact factor: 17.367

Review 5.  Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.

Authors:  J G F Cleland; A Torabi; N K Khan
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

6.  Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction.

Authors:  Weishuai An; Yongsheng Yu; Yuefan Zhang; Zhigang Zhang; Yunhua Yu; Xianxian Zhao
Journal:  Br J Pharmacol       Date:  2019-01-08       Impact factor: 8.739

7.  Heart failure in post-MI patients with persistent IRA occlusion: prevalence, risk factors, and the long-term effect of PCI in the Occluded Artery Trial (OAT).

Authors:  Rahul R Jhaveri; Harmony R Reynolds; Stuart D Katz; Raban Jeger; Elzbieta Zinka; Sandra A Forman; Gervasio A Lamas; Judith S Hochman
Journal:  J Card Fail       Date:  2012-11       Impact factor: 5.712

8.  Long-term trends in the incidence of heart failure after myocardial infarction.

Authors:  Raghava S Velagaleti; Michael J Pencina; Joanne M Murabito; Thomas J Wang; Nisha I Parikh; Ralph B D'Agostino; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-10-27       Impact factor: 29.690

9.  National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998-2010.

Authors:  Jersey Chen; Angela Fu-Chi Hsieh; Kumar Dharmarajan; Frederick A Masoudi; Harlan M Krumholz
Journal:  Circulation       Date:  2013-11-04       Impact factor: 29.690

Review 10.  Sex differences in long-term mortality after myocardial infarction: a systematic review.

Authors:  Emily M Bucholz; Neel M Butala; Saif S Rathore; Rachel P Dreyer; Alexandra J Lansky; Harlan M Krumholz
Journal:  Circulation       Date:  2014-07-22       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.